Pyridam Farma (Indonesia) Performance
| PYFA Stock | IDR 175.00 13.00 6.91% |
The company holds a Beta of 0.49, which implies possible diversification benefits within a given portfolio. As returns on the market increase, Pyridam Farma's returns are expected to increase less than the market. However, during the bear market, the loss of holding Pyridam Farma is expected to be smaller as well. At this point, Pyridam Farma Tbk has a negative expected return of -0.17%. Please make sure to check Pyridam Farma's value at risk, skewness, accumulation distribution, as well as the relationship between the potential upside and kurtosis , to decide if Pyridam Farma Tbk performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
Very Weak
Weak | Strong |
Over the last 90 days Pyridam Farma Tbk has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest conflicting performance, the Stock's forward-looking signals remain persistent and the latest mess on Wall Street may also be a sign of long-standing gains for the company institutional investors. ...more
| Begin Period Cash Flow | 9.6 B | |
| Total Cashflows From Investing Activities | -371.6 B |
Pyridam |
Pyridam Farma Relative Risk vs. Return Landscape
If you would invest 21,600 in Pyridam Farma Tbk on December 23, 2024 and sell it today you would lose (4,100) from holding Pyridam Farma Tbk or give up 18.98% of portfolio value over 90 days. Pyridam Farma Tbk is generating negative expected returns and assumes 6.3898% volatility on return distribution over the 90 days horizon. Simply put, 57% of stocks are less volatile than Pyridam, and 99% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
Pyridam Farma Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Pyridam Farma's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Pyridam Farma Tbk, and traders can use it to determine the average amount a Pyridam Farma's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.0268
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | PYFA |
Estimated Market Risk
| 6.39 actual daily | 57 57% of assets are less volatile |
Expected Return
| -0.17 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.03 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Pyridam Farma is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Pyridam Farma by adding Pyridam Farma to a well-diversified portfolio.
Pyridam Farma Fundamentals Growth
Pyridam Stock prices reflect investors' perceptions of the future prospects and financial health of Pyridam Farma, and Pyridam Farma fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Pyridam Stock performance.
| Return On Equity | 0.87 | |||
| Return On Asset | -0.17 | |||
| Profit Margin | 0.36 % | |||
| Operating Margin | (0.37) % | |||
| Current Valuation | 1.29 T | |||
| Shares Outstanding | 535.08 M | |||
| Price To Book | 1.12 X | |||
| Price To Sales | 0.65 X | |||
| Revenue | 630.53 B | |||
| EBITDA | 59.32 B | |||
| Total Debt | 362.8 B | |||
| Book Value Per Share | 851.94 X | |||
| Cash Flow From Operations | 39.59 B | |||
| Earnings Per Share | 514.07 X | |||
| Total Asset | 806.22 B | |||
About Pyridam Farma Performance
By examining Pyridam Farma's fundamental ratios, stakeholders can obtain critical insights into Pyridam Farma's financial health, operational efficiency, and overall profitability. These insights assist in making well-informed investment and management decisions. For example, a high Return on Assets and Return on Equity would indicate that Pyridam Farma is effectively utilizing its assets and equity to generate significant profits, enhancing its appeal to investors. On the other hand, low ROA and ROE values could reveal issues in asset and equity management, highlighting the need for operational improvements.
Things to note about Pyridam Farma Tbk performance evaluation
Checking the ongoing alerts about Pyridam Farma for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Pyridam Farma Tbk help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Pyridam Farma Tbk generated a negative expected return over the last 90 days | |
| Pyridam Farma Tbk has high historical volatility and very poor performance | |
| About 60.0% of the company outstanding shares are owned by corporate insiders |
- Analyzing Pyridam Farma's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Pyridam Farma's stock is overvalued or undervalued compared to its peers.
- Examining Pyridam Farma's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Pyridam Farma's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Pyridam Farma's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Pyridam Farma's stock. These opinions can provide insight into Pyridam Farma's potential for growth and whether the stock is currently undervalued or overvalued.
Other Information on Investing in Pyridam Stock
Pyridam Farma financial ratios help investors to determine whether Pyridam Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Pyridam with respect to the benefits of owning Pyridam Farma security.